Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing robot-assisted and open surgery for esophageal cancer

Official title: Clinical Trial Of Safety Of Robot-assisted Thoracic Approach Verus Open Transthoracic Esophagectomy in Esophageal Cancer.

Run by Hospital Universitari de Bellvitge · NCT04652180 · Data updated 2026-11-12

This study is testing if robot-assisted surgery for esophageal cancer is as effective or better than traditional open surgery in helping patients recover and live well after the operation.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment108 (estimated)
SponsorHospital Universitari de Bellvitge
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (L'Hospitalet de Llobregat, Barcelona)
StatusRecruiting
StartedNovember 6, 2020
Main results expectedDecember 30, 2025
Study endsDecember 30, 2026
Registry record updatedMarch 1, 2023
Trial IDNCT04652180 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older with histologically confirmed resectable esophageal cancer.

Probably not a fit

Patients with advanced stage IV esophageal cancer or those with contraindications for transthoracic esophagectomy will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial is a randomized controlled trial that aims to compare the effectiveness of a robot-assisted thoracic approach to the traditional open transthoracic esophagectomy for patients with resectable esophageal cancer. The study will evaluate postoperative complications, blood loss, hospital stay duration, and overall quality of life following surgery. By analyzing these factors, the trial seeks to determine if the robot-assisted method can provide similar or better oncologic outcomes while reducing complications compared to the standard open approach.

Why it matters

Potential benefit: If successful, this approach could lead to fewer postoperative complications and improved recovery for patients undergoing surgery for esophageal cancer.

How similar studies have gone: Previous studies have shown promising results for minimally invasive techniques in esophageal surgery, suggesting potential benefits of robot-assisted approaches, although this specific comparison is less commonly tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years.
* Histologically proven adenocarcinoma, squamous cell carcinoma, undifferentiated carcinoma or carcinoma of the gastro-esophageal junction (GEJ) Siewert I or II.
* Surgical resectable (T1-4a, N0-3, M0).
* Childbearing potential women (period between menarche and menopause), pregnancy negative test is mandatory.
* Written informed consent.

Exclusion Criteria:

* Stage IV or GEJ Siewert III esophageal cancer.
* Contraindication of transthoracic esophagectomy in two fields.
* Pre- or concomitant cancer or conditions which interferes with the study (e.g. prior thoracic surgery or trauma. Rationale: these patients may undergo open resection).

Where it's running

  • Hospital Universitari de Bellvitge
    L'Hospitalet de Llobregat, Barcelona, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.